Table 2.
Etiology | Risk for PNR to Anti-TNF Terapy |
---|---|
Drug-related factors | Low drug concentrations (pharmacoki-netics): nonimmune clearance, immu-nogenicity (development of antidrug antibodies) |
Adequate drug concentrations (pharma-codynamics): mechanistic failure | |
Patient-related factors | Smoking, obesity |
Disease-related factors | Longstanding disease (>2 years), isolated small bowel disease, upper gastrointestinal involvement, severe intestinal infammation, hypoalbuminemia |
PNR, primary nonresponse; TNF, tumor necrosis factor |